The concrete goal is to support and facilitate access to sources of debt and equity financing by innovative companies of all sizes and also by research centres and universities, public-private partnerships, special-purpose companies or projects, and joint ventures.
Particular support is required for innovative SMEs (and in some sectors, microenterprises), especially in the start-up phase or after diversifying into new markets. The availability of early-stage and growth-stage equity finance for innovative firms also needs improvement, with better access to finance a must for the concept and proof-of-concept stage of the innovation process. For commercial-scale, first-of-a-kind demonstration plants and their market uptake and wider deployment, a more predictable and stable supply of risk capital is needed: this is a key factor in attracting the public and private input necessary for commercialisation to happen. The availability of debt finance for R&I infrastructures also needs enhancing.
InnovFin – EU Finance for Innovators is the name under which the EU promotes a range of debt and equity products and advisory services in order to effectively give a boost to the availability of finance for research and innovation activities in Europe.
InnovFin - EU Finance for Innovators consists of a range of tailored products – from guarantees for intermediaries that lend to SMEs to direct loans to enterprises - helping support the smallest to the largest R&I projects in the EU and countries associated to Horizon 2020, the new EU research programme for 2014-20.
The InnovFin products operates in conjunction with those of EU programme for the Competitiveness of Enterprises and Small and Medium-sized Enterprises (COSME).
The European Investment Bank (EIB) and the European Investment Fund (EIF) play an important role, as entrusted entities, in implementing each financial instrument facility on behalf of and in partnership with the European Commission.
The European Investment Bank provides loans to medium to larger companies, or guarantees to banks lending to them. It also provides a range of technical assistance and advisory services, in order to help project promoters to make research, development and innovation bankable. In addition, two thematic finance products were launched in 2015, for the support of combating infectious diseases and high-risk energy demonstration projects.
Apart from access to finance mainly through debt and equity instruments implemented by the EIB, Horizon 2020 also support in particular SMEs and start-ups to become more investment-ready via various capacity-building actions, directed at them and their national support organisations:
For examples of more accompanying measures, please consult the Work Programmes on Access to Risk Finance at the bottom of the page.
The European Fund for Strategic Investments (EFSI) is widening the opportunities for finance for innovation support both under its Infrastructure & Innovation and SME windows. The products under EFSI will be implemented by the European Investment Bank group; more information is available here.
RDI is not only a priority sector under the EFSI Infrastructure and Innovation Window (IIW). It is a horizontal dimension, also present in other priority sectors of IIW (like Digital, Energy, Transport, etc.), as well as in the EFSI SME Window (SMEW) where debt and equity finance products are supporting the growth of RDI-driven / innovative SMEs and small mid-caps. This explains why the total level of EFSI financing devoted to RDI is 23% at the end of May 2016.